Skip to main content
NCBI home page
Clinical and Experimental Immunology logoLink to Clinical and Experimental Immunology
. 1977 Nov;30(2):317–322.

Some immunological effects of penicillamine.

D M Chen, G Di Sabato, L Field, A A Gallo, S Harshman
PMCID: PMC1541119  PMID: 304785

Abstract

Immunological effects of D- and D,L-penicillamine (PA) were studied in efforts to develop assays for synthetic D or D,L analogs and to contribute to the understanding of the mechanism(s) of action of D-PA in rheumatoid arthritis. At the highest doses tolerated by mice, D,L-PA did not significantly inhibit the development of haemagglutinating antibodies in vivo. In studies in vitro with T lymphocytes, D-PA at 1 mM concentration inhibited both concanavalin A- and phytohaemagglutinin-induced transformation as assayed by [3H]thymidine incorporation, but D-PA concentrations of 5 mM were required to inhibit concanavalin A-induced amino acid uptake. No effect of D-PA was observed either on the induction of cytotoxic T cells or on the attack of specifically sensitized T cells on target cells. It is of interest that D-PA at 1 mM concentration did inhibit lipopolysaccharide-induced transformation, which predominately stimulates B lymphocytes. The effects of PA on the induced transformation of T and B cells deserve further attention for studies with analogs of PA.

Full text

PDF
317

Selected References

These references are in PubMed. This may not be the complete list of references from this article.

  1. ALTMAN K., TOBIN M. S. SUPPRESSION OF THE PRIMARY IMMUNE RESPONSE INDUCED BY D-L PENICILLAMINE. Proc Soc Exp Biol Med. 1965 Feb;118:554–557. doi: 10.3181/00379727-118-29903. [DOI] [PubMed] [Google Scholar]
  2. Bluestone R., Goldberg L. S. Effect of D-penicillamine on serum immunoglobulins and rheumatoid factor. Ann Rheum Dis. 1973 Jan;32(1):50–52. doi: 10.1136/ard.32.1.50. [DOI] [PMC free article] [PubMed] [Google Scholar]
  3. Brandt L., Svensson B. Letter: Effect of penicillamine on peripheral-blood lymphocytes in rheumatoid arthritis. Lancet. 1975 Feb 15;1(7903):394–395. doi: 10.1016/s0140-6736(75)91309-4. [DOI] [PubMed] [Google Scholar]
  4. DU VIGNEAUD V., KUCHINSKAS E. J. An increased vitamin B6 requirement in the rat on a diet containing L-penicillamine. Arch Biochem Biophys. 1957 Jan;66(1):1–9. doi: 10.1016/0003-9861(57)90531-3. [DOI] [PubMed] [Google Scholar]
  5. Di Sabato G., Chen D. M., Erickson J. W. Production by murine spleen cells of an activity stimulating the PHA-responsiveness of thymus lymphocytes. Cell Immunol. 1975 Jun;17(2):495–504. doi: 10.1016/s0008-8749(75)80053-0. [DOI] [PubMed] [Google Scholar]
  6. Doherty P. C., Zinkernagel R. M. T-cell-mediated immunopathology in viral infections. Transplant Rev. 1974;19(0):89–120. doi: 10.1111/j.1600-065x.1974.tb00129.x. [DOI] [PubMed] [Google Scholar]
  7. Field L., Hanley W. S., Kelly P. L., Sanders W. J., White J. E., Jaffe I. A., Merryman P. Biologically oriented organic sulfur chemistry. 12. Further principles of structure-activity relationships for penicillamine analogs and derivatives. J Med Chem. 1973 Oct;16(10):1152–1157. doi: 10.1021/jm00268a019. [DOI] [PubMed] [Google Scholar]
  8. HUEBNER K. F., GENGOZIAN N. DEPRESSION OF THE PRIMARY IMMUNE RESPONSE BY DL-PENICILLAMINE. Proc Soc Exp Biol Med. 1965 Feb;118:561–565. doi: 10.3181/00379727-118-29905. [DOI] [PubMed] [Google Scholar]
  9. Jaffe I. A. Penicillamine treatment of rheumatoid arthritis: effect on immune complexes. Ann N Y Acad Sci. 1975 Jun 13;256:330–337. doi: 10.1111/j.1749-6632.1975.tb36059.x. [DOI] [PubMed] [Google Scholar]
  10. Jaffe I. A. The effect of penicillamine on the laboratory parameters in rheumatoid arthritis. Arthritis Rheum. 1965 Dec;8(6):1064–1079. doi: 10.1002/art.1780080606. [DOI] [PubMed] [Google Scholar]
  11. Jaffe I. A. The treatment of rheumatoid arthritis and necrotizing vasculitis with penicillamine. Arthritis Rheum. 1970 Jul-Aug;13(4):436–443. doi: 10.1002/art.1780130412. [DOI] [PubMed] [Google Scholar]
  12. Jasin H. E., Cooke T. D., Hurd E. R., Smiley J. D., Ziff M. Immunologic models used for the study of rheumatoid arthritis. Fed Proc. 1973 Feb;32(2):147–152. [PubMed] [Google Scholar]
  13. Liyanage S. P., Currey H. L. Failure of oral D-penicillamine to modify adjuvant arthritis or immune response in the rat. Ann Rheum Dis. 1972 Nov;31(6):521–521. doi: 10.1136/ard.31.6.521. [DOI] [PMC free article] [PubMed] [Google Scholar]
  14. Messner R. P. Clinical aspects of T- and B-lymphocytes in rheumatic diseases. Arthritis Rheum. 1974 Jul-Aug;17(4):339–346. doi: 10.1002/art.1780170402. [DOI] [PubMed] [Google Scholar]
  15. Schumacher K., Maerker-Alzer G., Preuss R. Effect of D-penicillamine on lymphocyte function. Arzneimittelforschung. 1975 Apr;25(4):603–606. [PubMed] [Google Scholar]
  16. Schumacher K., Maerker-Alzer G., Schaaf W. Influence of D-penicillamine on the immune response of mice. Arzneimittelforschung. 1975 Apr;25(4):600–603. [PubMed] [Google Scholar]
  17. Sweetman B. J., Vestling M. M., Ticaric S. T., Kelly P. L., Field L., Merryman P., Jaffe I. A. Biologically oriented organic sulfur chemistry. 8. Structure-activity relationships of penicillamine analogs and derivatives. J Med Chem. 1971 Sep;14(9):868–872. doi: 10.1021/jm00291a024. [DOI] [PubMed] [Google Scholar]
  18. Wettenhall R. E., London D. R. Evidence for translational control of "early" protein synthesis in lymphocytes stimulated with concanavaline A. Biochim Biophys Acta. 1974 May 17;349(2):214–225. doi: 10.1016/0005-2787(74)90082-3. [DOI] [PubMed] [Google Scholar]
  19. Zinkernagel R. M., Doherty P. C. Characteristics of the interaction in vitro between cytotoxic thymus-derived lymphocytes and target monolayers infected with lymphocytic choriomeningitis virus. Scand J Immunol. 1974;3(3):287–294. doi: 10.1111/j.1365-3083.1974.tb01259.x. [DOI] [PubMed] [Google Scholar]

Articles from Clinical and Experimental Immunology are provided here courtesy of British Society for Immunology

RESOURCES